BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35322195)

  • 1. Low-grade non-intestinal-type sinonasal adenocarcinoma: a histologically distinctive but molecularly heterogeneous entity.
    Rooper LM; Thompson LDR; Gagan J; Hwang JSG; London NR; Mikula MW; Stevens TM; Bishop JA
    Mod Pathol; 2022 Sep; 35(9):1160-1167. PubMed ID: 35322195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETV6 Gene Rearrangements Characterize a Morphologically Distinct Subset of Sinonasal Low-grade Non-intestinal-type Adenocarcinoma: A Novel Translocation-associated Carcinoma Restricted to the Sinonasal Tract.
    Andreasen S; Skálová A; Agaimy A; Bishop JA; Laco J; Leivo I; Franchi A; Larsen SR; Erentaite D; Ulhøi BP; von Buchwald C; Melchior LC; Michal M; Kiss K
    Am J Surg Pathol; 2017 Nov; 41(11):1552-1560. PubMed ID: 28719468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sinonasal mixed transitional epithelial-seromucinous papillary glandular neoplasms with BRAF p.V600E mutations - sinonasal analogues to the sialadenoma papilliferum family tumors.
    Patel S; Snyderman CH; Müller SK; Agaimy A; Seethala RR
    Virchows Arch; 2022 Oct; 481(4):565-574. PubMed ID: 35715530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
    Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
    Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Subset of Sinonasal Non-Intestinal Type Adenocarcinomas are Truly Seromucinous Adenocarcinomas: A Morphologic and Immunophenotypic Assessment and Description of a Novel Pitfall.
    Purgina B; Bastaki JM; Duvvuri U; Seethala RR
    Head Neck Pathol; 2015 Dec; 9(4):436-46. PubMed ID: 25690258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.
    Rooper LM; Agaimy A; Dickson BC; Dueber JC; Eberhart CG; Gagan J; Hartmann A; Khararjian A; London NR; MacMillan CM; Palsgrove DN; Nix JS; Sandison A; Stoehr R; Truong T; Weinreb I; Bishop JA
    Am J Surg Pathol; 2021 Dec; 45(12):1682-1693. PubMed ID: 34049316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary Mucinous Adenocarcinoma Is a Histologically Diverse Single Entity With Recurrent AKT1 E17K Mutations: Clinicopathologic and Molecular Characterization With Proposal for a Unified Classification.
    Rooper LM; Argyris PP; Thompson LDR; Gagan J; Westra WH; Jordan RC; Koutlas IG; Bishop JA
    Am J Surg Pathol; 2021 Oct; 45(10):1337-1347. PubMed ID: 33739781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature.
    Chłopek M; Lasota J; Thompson LDR; Szczepaniak M; Kuźniacka A; Hińcza K; Kubicka K; Kaczorowski M; Newford M; Liu Y; Agaimy A; Biernat W; Durzyńska M; Dziuba I; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kato H; Kopczyński J; Michal M; Michal M; Pęksa R; Prochorec-Sobieszek M; Starzyńska A; Takahashi S; Wasąg B; Kowalik A; Miettinen M
    Mod Pathol; 2022 Nov; 35(11):1609-1617. PubMed ID: 35978013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor expression and KRAS and BRAF mutations: study of 39 sinonasal intestinal-type adenocarcinomas.
    Projetti F; Durand K; Chaunavel A; Léobon S; Lacorre S; Caire F; Bessède JP; Moreau JJ; Coulibaly B; Labrousse F
    Hum Pathol; 2013 Oct; 44(10):2116-25. PubMed ID: 23791006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colloid Pattern of Salivary Mucinous Adenocarcinomas With Recurrent BRAF V600E Mutations.
    Zhang Y; Zhou Z; Liu X; Zhu L; Cui Y; Li TJ; Zhou CX
    Am J Surg Pathol; 2024 Mar; 48(3):266-274. PubMed ID: 38050369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
    Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
    Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study.
    Ozolek JA; Barnes EL; Hunt JL
    Arch Pathol Lab Med; 2007 Apr; 131(4):530-7. PubMed ID: 17425380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.
    Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O
    Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V600E BRAF versus Non-V600E BRAF Mutated Lung Adenocarcinomas: Cytomorphology, Histology, Coexistence of Other Driver Mutations and Patient Characteristics.
    Salimian KJ; Fazeli R; Zheng G; Ettinger D; Maleki Z
    Acta Cytol; 2018; 62(2):79-84. PubMed ID: 29320776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications.
    Xu B; Aryeequaye R; Wang L; Katabi N
    Head Neck Pathol; 2018 Jun; 12(2):274-278. PubMed ID: 28980201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Molecular Profiling of Sinonasal Teratocarcinosarcoma Highlights Recurrent SMARCA4 Inactivation and CTNNB1 Mutations.
    Rooper LM; Agaimy A; Gagan J; Simpson RHW; Thompson LDR; Trzcinska AM; Ud Din N; Bishop JA
    Am J Surg Pathol; 2023 Feb; 47(2):224-233. PubMed ID: 36206446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations.
    Bishop JA; Nakaguro M; Whaley RD; Ogura K; Imai H; Laklouk I; Faquin WC; Sadow PM; Gagan J; Nagao T
    Histopathology; 2021 Sep; 79(3):338-346. PubMed ID: 33135196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary gland papillary adenocarcinoma with intestinal-like features: Clinicopathologic, immunohistochemical, and genetic study of six cases.
    Liu X; Zhang Y; Zhou CX; Li TJ
    J Oral Pathol Med; 2022 Feb; 51(2):172-179. PubMed ID: 34982488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade tracheal adenocarcinoma with ETV6::NTRK3 fusion: unique morphology akin to subsets of sinonasal low-grade non-intestinal-type adenocarcinoma.
    Kishikawa S; Hayashi T; Shimizu J; Fuwa B; Nonomura A; Saito T; Yatabe Y; Yao T
    Virchows Arch; 2022 Nov; 481(5):793-797. PubMed ID: 35670854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.